ZNF468 and breast cancer: To investigate whether ZNF468 dysregulation modulates the effectiveness of cisplatin, the BC cells transfected with ZNF468 siRNAs or overexpression vectors were treated with different concentrations of cisplatin and subjected to CCK-8 analysis of cell viability.